|Security||MDCL / Medicine Man Technologies Inc. (58468U106)|
|Industry||Cannabis and Medical Marijuana Dispensaries|
|Institutional Shares||701,390 - 2.73%|
|Common Shares Outstanding||25,644,981 shares (as of 2018-06-30)|
|Institutional Value||$ 1,018,000 USD|
Institutional Stock Ownership and Shareholders
Medicine Man Technologies Inc. (OTC:MDCL) has 2 institutional investors and shareholders that have
filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 701,390 shares.
Largest shareholders include
North Star Asset Management Inc, and CENTRAL TRUST Co.
Medicine Man Technologies Inc. (OTC:MDCL) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.
|NORTH STAR ASSET MANAGEMENT INC||701,240||701,140||-0.01||1,220||1,017||-16.64|
|CENTRAL TRUST Co||250||250||0.00||0||1|
2017-11-14 - Asif
Medicine Man Technologies was incorporated on March 20, 2014, in the State of Nevada. On May 1, 2014, the company entered into an exclusive Technology License Agreement with Medicine Man Denver, Inc., f/k/a Medicine Man Production Corporation, a Colorado corporation (“Medicine Man Denver”) whereby Medicine Man Denver granted it a license to use all of their proprietary processes they have developed, implemented and practiced at its cannabis facilities relating to the commercial growth, cultivation, marketing and distribution of medical marijuana and recreational marijuana pursuant to relevant state laws and the right to use and to license such information, including trade secrets, skills and experience (present and future) (the “Medicine Man Denver License Agreement”). The company commenced its business on May 1, 2014 and currently generate revenues derived from licensing agreements with cannabis related entities, as well as sponsoring seminars offered to the cannabis industry an...
Related News Stories
When it comes to cannabis, we’ve come a long way since former President Bill Clinton denied ever inhaling. With the previous presidential administration’s frankness on the matter, marijuana has become more blasé. Naturally, marijuana stocks have also increased in popularity, where we have more choices today than was previously thought possible. (38-4)
DENVER, CO / ACCESSWIRE / October 9, 2018 / Medicine Man Technologies Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or "Company"), one of the United States' leading cannabis branding and consulting companies today provided the following client and business update.
Some market components, such as small-capitalization companies, require little coaxing. Whether it’s their potential to produce incredible gains, or the chance to get in early on a burgeoning industry, small-cap stocks present enticing opportunities. While we should all be aware of their highly risky reputation, most investment strategies benefit from their inclusion. (97-6)
When it comes to cannabis, we’ve come a long way since former President Bill Clinton denied ever inhaling. With the previous presidential administration’s frankness on the matter, marijuana has become more blasé. Naturally, marijuana stocks have also increased in popularity, where we have more choices today than was previously thought possible. (38-18)
Medicine Man Technologies, Inc. (OTCQB:MDCL) Q2 2018 Earnings Conference Call August 9, 2018 10:30 AM ET (0-1)
as of ET